Identification of preoperative factors associated with outcomes following surgical management of intra‐abdominal recurrent or metastatic GIST following neoadjuvant tyrosine kinase inhibitor therapy

The role of surgical resection in the treatment of patients with metastatic/recurrent gastrointestinal stromal tumors (GIST) is unclear. The aim of this study was to identify preoperative factors associated with oncologic outcomes for recurrent/metastatic GIST after tyrosine kinase inhibitor (TKI) therapy.